Grant: CIHR Fellowship
Direct Payment
$150,000.00
Transcriptional networks regulating neurodegeneration and neuroprotection
FY 2008-09
Summary
Neurodegenerative diseases are a group of diseases that are characterized by the progressive loss of neurons. These diseases include Huntington's, Alzheimer's, ALS and a number of ataxias. There are currently no treatments that delay the progression of Huntington's disease or Alzheimer's disease, the two most common forms of neurodegenerative disease. Mutations in genes that result in these conditions have been identified, however, how exactly these mutations result in neuronal cell death is not completely understood. Studies have identified hundreds of genes that have been implicated in the progression of these diseases. We propose to analyze how the expression of these genes is regulated in the model organism, C. elegans in order to understand how these genes function together. Used a more simplified genetic system, we believe that we can identify key factors involved in these diseases and test them genetically. Identifying these key mediators will aid in drug discovery by identifying key targets for therapeutic intervention.
Department
Program
CIHR Fellowship
Recipient
Location
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
181420
Name
MacNeil Lesley T
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Transcriptional networks regulating neurodegeneration and neuroprotection
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Alzheimer'S Disease; Human Disease Models; Huntington'S Disease; Model Organism; Neurodegeneration; Systems Biology; Transcription
Abstract
Neurodegenerative diseases are a group of diseases that are characterized by the progressive loss of neurons. These diseases include Huntington's, Alzheimer's, ALS and a number of ataxias. There are currently no treatments that delay the progression of Huntington's disease or Alzheimer's disease, the two most common forms of neurodegenerative disease. Mutations in genes that result in these conditions have been identified, however, how exactly these mutations result in neuronal cell death is not completely understood. Studies have identified hundreds of genes that have been implicated in the progression of these diseases. We propose to analyze how the expression of these genes is regulated in the model organism, C. elegans in order to understand how these genes function together. Used a more simplified genetic system, we believe that we can identify key factors involved in these diseases and test them genetically. Identifying these key mediators will aid in drug discovery by identifying key targets for therapeutic intervention.
Competitiondate
200902
Approvedterm2
3 yrs 0 mth
Pinamesdelim
MacNeil, Lesley T
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~